8 results about "Immunological tests" patented technology

A detection method for detecting a substance to be detected in an immunological test sample, the detection method comprising a labeling step in which a complex of the substance to be detected and a labeling body is formed in the presence of at least one selected from imidazole and derivatives thereof, a pH buffer, and a polyvalent metal ion, the labeling body comprising a first probe molecule capable of binding to the substance to be detected and a label.

The invention relates to the technical field of microbiological detection, in particular to a CRISPR / Cas12a-based detection kit and a CRISPR / Cas12a-based detection method for detecting bovine pasteurella multocida. An isothermal amplification primer pair is designed on the basis of a conserved kmt gene of bovine pasteurella multocida, the kmt gene is subjected to amplification marking by virtue of an isothermal amplification technology, and the detection kit for detecting bovine pasteurella multocida is constructed by virtue of the high-specificity recognition capability of CRISPR / Cas12a and the visualization advantage of an immune test strip. By utilizing the detection kit and the detection method provided by the invention, the bovine pasteurella multocida can be rapidly detected under normal-temperature and constant-temperature conditions, and the detection kit and the detection method have the advantages that the result is visual and accurate, the sensitivity is high, the operation steps are simple and convenient, and large precise instruments are not needed. The kit provided by the invention is suitable for various field detection scenes such as farms and grassroots veterinary stations, and an efficient tool is provided for early prevention and control of cattle pasteurellosis.

The utility model relates to the field of immunological detection, in particular to a blood extraction device for immunological detection, which comprises a support frame, a first rotating rod mounted in the support frame, mounting frames arranged on the inner walls of two ends of the support frame, a bearing frame mounted on the first rotating rod, and a mounting seat arranged at the bottom of the bearing frame. Blood storage test tubes are inserted into the tops of the mounting seats; a fixing plate is installed on the outer wall of the supporting frame, a second driving part is installed on the fixing plate, a one-way screw rod is installed on the second driving part, a sliding block is connected to the one-way screw rod, a connecting plate is arranged on the sliding block, an extraction pipe is embedded in the connecting plate, a telescopic rod is embedded in the connecting plate, a connecting block is arranged at the top of the telescopic rod, and a connecting rod is arranged at the bottom of the connecting block; a piston plate is arranged at the bottom of the connecting rod, a sealing cavity and a liquid discharging assembly are formed in the piston plate, blood for immunological detection can be effectively, conveniently and automatically extracted and treated in sequence, and therefore the extraction device can be conveniently used.

This application relates to the field of data processing technology, and in particular to a method, system, device, medium, and product for generating rheumatoid and immunological test reports. The method includes receiving a VCF file from NGS sequencing, a report output directory, and a report output template to generate an order number; naming the VCF file, patient information file, quality control parameter file, and filter parameter file according to a naming convention including the order number, and saving them to the report output directory; extracting patient information, quality control parameters, filter thresholds, and a list of target rheumatoid and immunological diseases, and combining the paths of relevant files to generate, verify, and save a configuration file containing the order number to the report output directory; starting a Docker container to analyze the VCF file, and automatically filling the analysis results, patient information, and quality control parameters into the report output template, generating and saving a rheumatoid and immunological test report containing the order number to the report output directory, thus achieving fully automated generation and analysis from data input to result output.

The present disclosure provides improved methods of processing a fecal sample by a human subject in which the fecal sample is collected at home and subsequently delivered to a medical diagnostics laboratory. As described herein, the means of collecting and processing the fecal sample can desirably reduce the number of steps undertaken by the human subject, including avoiding steps of removing or separating the fecal sample into multiple portions. Furthermore, the human subject does not have to perform an immunological test (e.g., a fecal immunochemical test (FIT) or an immunochemical fecal occult blood test (iFOBT)) at home.

This invention discloses a Mycoplasma pneumoniae antibody detection kit based on immunoturbidimetry, belonging to the field of clinical immunology testing. It includes solutions R1 and R2. Solution R1 is a dispersion of double-coupled latex microspheres coated with natural Mycoplasma pneumoniae antigens, and solution R2 is a sample diluent containing an enhancer. The test samples can be serum, plasma, or whole blood samples, and it is applicable to biochemical analyzers, protein analyzers, or combined blood cell and immunoturbidimetric analyzers. The kit prepared by this invention can be used on various instruments, has a wide range of detection targets, and can be coupled with other instruments to detect various clinically valuable blood indicators, further shortening the testing time. It solves the problems of poor accuracy, low efficiency, and limited application scenarios caused by the subjective interpretation of results, long processing time, and limited applicability of blood samples in existing technologies. It can effectively simplify the testing process and improve diagnostic efficiency.

The present disclosure provides improved methods of processing a fecal sample by a human subject in which the fecal sample is collected at home and subsequently delivered to a medical diagnostics laboratory. As described herein, the means of collecting and processing the fecal sample can desirably reduce the number of steps undertaken by the human subject, including avoiding steps of removing or separating the fecal sample into multiple portions. Furthermore, the human subject does not have to perform an immunological test (e.g., a fecal immunochemical test (FIT) or an immunochemical fecal occult blood test (iFOBT)) at home.